MMWR. Morbidity and mortality weekly report最新文献_第7页

Progress Toward Elimination of Mother-to-Child Transmission of Hepatitis B Virus - Region of the Americas, 2012-2022. 消除乙型肝炎病毒母婴传播的进展情况 - 美洲地区，2012-2022 年。

IF 25.4 1区医学

MMWR. Morbidity and mortality weekly report Pub Date : 2024-07-25 DOI: 10.15585/mmwr.mm7329a3

Mary M Alleman, Leandro Soares Sereno, Alvaro Whittembury, Xi Li, Marcela Contreras, Carmelita Pacis-Tirso, Martha Velandia Gonzalez, Karen Broome, Sandra Jones, Daniel Salas, Monica Alonso, Rania A Tohme, Annemarie Wasley

{"title":"Progress Toward Elimination of Mother-to-Child Transmission of Hepatitis B Virus - Region of the Americas, 2012-2022.","authors":"Mary M Alleman, Leandro Soares Sereno, Alvaro Whittembury, Xi Li, Marcela Contreras, Carmelita Pacis-Tirso, Martha Velandia Gonzalez, Karen Broome, Sandra Jones, Daniel Salas, Monica Alonso, Rania A Tohme, Annemarie Wasley","doi":"10.15585/mmwr.mm7329a3","DOIUrl":"10.15585/mmwr.mm7329a3","url":null,"abstract":"In 2022, an estimated 5 million persons in the World Health Organization Region of the Americas (AMR) were living with chronic hepatitis B virus (HBV) infection, the leading cause of hepatocellular carcinoma and cirrhosis worldwide. Most chronic infections are acquired through mother-to-child transmission (MTCT) or horizontal transmission during childhood and are preventable with hepatitis B vaccination, including a birth dose (HepB-BD), followed by 2-3 additional doses (HepB3) in infancy. The Pan American Health Organization (PAHO) Elimination of MTCT of HBV infection strategy is intended to reduce chronic HBV infection (measured by hepatitis B surface antigen [HBsAg] seroprevalence) to ≤0.1% among children by achieving 1) ≥95% coverage with HepB-BD and HepB3; and 2) ≥80% of pregnant women received testing for HBsAg, and provision of hepatitis B immunoglobulin to HBV-exposed neonates. By 2012, all 51 AMR countries and territories (countries) provided HepB3 nationwide, and by 2021, 34 (67%) provided HepB-BD nationwide. Mathematical models estimate that HBsAg seroprevalence in children is ≤0.1% in 14 (28%) of 51 countries and at the regional level. Three (6%) of 51 countries met the 95% coverage targets for both HepB3 and HepB-BD during both 2021 and 2022. Of these, two have likely met criteria for the elimination of MTCT of HBV infection. However, in 2022, HepB3 coverage had declined by ≥10 percentage points in 15 (37%) of 41 countries with 2012 coverage data for comparison. These declines in HepB3 coverage, as well as the absence of HepB-BD in the routine immunization schedules in 17 countries, threaten PAHO's progress toward the elimination of MTCT of HBV infection. Efforts to introduce HepB-BD and maintain high HepB3 and HepB-BD coverage are needed.","PeriodicalId":18637,"journal":{"name":"MMWR. Morbidity and mortality weekly report","volume":"73 29","pages":"648-655"},"PeriodicalIF":25.4,"publicationDate":"2024-07-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11290908/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141759714","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Progress Toward Achieving and Sustaining Maternal and Neonatal Tetanus Elimination - Worldwide, 2000-2022. 2000-2022 年全球在实现和维持消除孕产妇和新生儿破伤风方面取得的进展。

IF 25.4 1区医学

MMWR. Morbidity and mortality weekly report Pub Date : 2024-07-18 DOI: 10.15585/mmwr.mm7328a1

Camille E Jones, Nasir Yusuf, Bilal Ahmed, Modibo Kassogue, Annemarie Wasley, Florence A Kanu

{"title":"Progress Toward Achieving and Sustaining Maternal and Neonatal Tetanus Elimination - Worldwide, 2000-2022.","authors":"Camille E Jones, Nasir Yusuf, Bilal Ahmed, Modibo Kassogue, Annemarie Wasley, Florence A Kanu","doi":"10.15585/mmwr.mm7328a1","DOIUrl":"10.15585/mmwr.mm7328a1","url":null,"abstract":"Tetanus remains a considerable cause of mortality among undervaccinated mothers and their infants following unhygienic deliveries, especially in low-income countries. Strategies of the maternal and neonatal tetanus elimination (MNTE) initiative, which targets 59 priority countries, include strengthening antenatal immunization of pregnant women with tetanus toxoid-containing vaccines (TTCVs); conducting TTCV supplementary immunization activities among women of reproductive age in high-risk districts; optimizing access to skilled birth attendants to ensure clean deliveries and umbilical cord care practices; and identifying and investigating suspected neonatal tetanus cases. This report updates a previous report and describes progress toward MNTE during 2000-2022. By December 2022, 47 (80%) of 59 priority countries were validated to have achieved MNTE. In 2022, among the 50 countries that reported coverage with ≥2 doses of TTCV among pregnant women, 16 (32%) reported coverage of ≥80%. In 2022, among 47 validated countries, 26 (55%) reported that ≥70% of births were assisted by skilled birth attendants. Reported neonatal tetanus cases worldwide decreased 89%, from 17,935 in 2000 to 1,995 in 2021; estimated neonatal tetanus deaths decreased 84%, from 46,898 to 7,719. However, the global disruption of routine immunization caused by the COVID-19 pandemic impeded MNTE progress. Since 2020, reported neonatal tetanus cases have increased in 18 (31%) priority countries. Integration of MNTE strategies into priority countries' national postpandemic immunization recovery activities is needed to achieve and sustain global elimination.","PeriodicalId":18637,"journal":{"name":"MMWR. Morbidity and mortality weekly report","volume":"73 28","pages":"614-621"},"PeriodicalIF":25.4,"publicationDate":"2024-07-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11262825/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141723913","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Childhood Lead Exposure Linked to Apple Cinnamon Fruit Puree Pouches - North Carolina, June 2023-January 2024. 儿童铅暴露与苹果肉桂果泥袋有关 - 北卡罗来纳州，2023 年 6 月至 2024 年 1 月。

IF 25.4 1区医学

MMWR. Morbidity and mortality weekly report Pub Date : 2024-07-18 DOI: 10.15585/mmwr.mm7328a2

Melanie D Napier, Alan Huneycutt, Carissa Moore, Chris Goforth, Marc Komlos, Veronica Bryant, Scott M Shone, Larry D Michael, Edward H Norman

{"title":"Childhood Lead Exposure Linked to Apple Cinnamon Fruit Puree Pouches - North Carolina, June 2023-January 2024.","authors":"Melanie D Napier, Alan Huneycutt, Carissa Moore, Chris Goforth, Marc Komlos, Veronica Bryant, Scott M Shone, Larry D Michael, Edward H Norman","doi":"10.15585/mmwr.mm7328a2","DOIUrl":"10.15585/mmwr.mm7328a2","url":null,"abstract":"Lead exposure is toxic even at low levels, resulting in impairments that can affect a child's lifelong success. In North Carolina, testing for lead is encouraged for all children at ages 1 and 2 years and required for children covered by Medicaid; investigations are performed to identify potential exposure sources for children with blood lead levels (BLLs) ≥5 μg/dL. During June-August 2023, routine lead testing identified four asymptomatic North Carolina children with BLLs ≥5 μg/dL. Home investigations identified only WanaBana brand apple cinnamon fruit puree pouches as a potential exposure source; product samples contained 1.9-3.0 ppm of lead. An expanded nationwide investigation led to identification of approximately 500 cases of childhood lead exposure believed to be linked to consumption of apple cinnamon purees, including 22 cases in North Carolina. Fewer than one half (45%) of the 22 North Carolina cases were among children covered by Medicaid. A coordinated multiagency communication strategy was implemented in North Carolina to notify consumers of the hazard and provide recommendations for preventing further exposure. The Food and Drug Administration issued a nationwide public health advisory on October 28, 2023; 2 days later, the manufacturer issued a voluntary recall. Routine testing of young children for lead exposure, combined with thorough environmental investigations, can identify emerging sources of lead exposure and limit further harm.","PeriodicalId":18637,"journal":{"name":"MMWR. Morbidity and mortality weekly report","volume":"73 28","pages":"622-627"},"PeriodicalIF":25.4,"publicationDate":"2024-07-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11262827/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141723911","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

QuickStats: Percentage* of Adults Aged ≥18 Years Who Walked for Transportation and Walked for Leisure in the Past 7 Days,^† by Urban-Rural Status^§ - United States, 2022. QuickStats：按城市-农村状况†分列的过去 7 天内步行交通和步行休闲的≥18 岁成年人的百分比* - 美国，2022 年。

IF 25.4 1区医学

MMWR. Morbidity and mortality weekly report Pub Date : 2024-07-18 DOI: 10.15585/mmwr.mm7328a4

引用次数: 0

Notes from the Field: Schedule I Substances Identified in Nootropic Gummies Containing Amanita muscaria or Other Mushrooms - Charlottesville, Virginia, 2023-2024. 现场笔记：2023-2024 年，弗吉尼亚州夏洛茨维尔，在含有鹅膏蕈或其他蘑菇的营养软糖中发现附表 I 物质。

IF 25.4 1区医学

MMWR. Morbidity and mortality weekly report Pub Date : 2024-07-18 DOI: 10.15585/mmwr.mm7328a3

Avery Michienzi, Jeremy Hamlin, Rita Farah, Lindsay Bazydlo

引用次数: 0

Human Case of Leptospirosis During a Canine Disease Outbreak - Wyoming, 2023. 2023 年怀俄明州犬科疾病爆发期间的钩端螺旋体病人类病例。

IF 25.4 1区医学

MMWR. Morbidity and mortality weekly report Pub Date : 2024-07-11 DOI: 10.15585/mmwr.mm7327a1

Brittney Waranius, Courtney Tillman, Clay Van Houten, Alexia Harrist, Rose Digianantonio, Hallie Hasel, Christine Atherstone, Emily Curren

{"title":"Human Case of Leptospirosis During a Canine Disease Outbreak - Wyoming, 2023.","authors":"Brittney Waranius, Courtney Tillman, Clay Van Houten, Alexia Harrist, Rose Digianantonio, Hallie Hasel, Christine Atherstone, Emily Curren","doi":"10.15585/mmwr.mm7327a1","DOIUrl":"10.15585/mmwr.mm7327a1","url":null,"abstract":"Leptospirosis is a zoonotic bacterial disease spread through the urine of infected animals; the typical incubation period is 5-14 days. In approximately 90% of human cases, illness is asymptomatic or mild, characterized by fever, chills, myalgia, nausea, vomiting, diarrhea, headache, calf pain, and conjunctival suffusion, but severe illness can progress to multiorgan dysfunction and death. Although Wyoming is considered a low-risk area for leptospirosis because of its cold and semiarid climate, the Wyoming Department of Health was notified of a probable human case in August 2023, the first reported in the state since 1983. The patient had occupational exposure to dogs but did not report other risk factors. The same week that the human patient's illness began, public health authorities received notification of an increase in canine leptospirosis cases. Public health authorities investigated to determine potential sources of infection, identify additional cases, and recommend control measures. After public health outreach activities were implemented, canine vaccination practices changed substantially in the affected city: a survey conducted after the outbreak revealed that all responding veterinary clinics in the affected city were recommending the vaccine more frequently to dog owners and reporting higher levels of owner compliance with vaccination recommendations. Increased vaccination coverage offers protection from leptospirosis for both dogs and persons exposed to them. Leptospirosis should be considered in the differential diagnosis of persons with occupational exposure to animals and clinically compatible signs and symptoms, including fever, chills, myalgia, nausea, vomiting, diarrhea, headache, calf pain, and conjunctival suffusion, irrespective of geographic location.","PeriodicalId":18637,"journal":{"name":"MMWR. Morbidity and mortality weekly report","volume":"73 27","pages":"602-606"},"PeriodicalIF":25.4,"publicationDate":"2024-07-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11254349/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141590647","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Erratum: Vol. 73, No. 21. 勘误：第 73 卷，第 21 期。

IF 25.4 1区医学

MMWR. Morbidity and mortality weekly report Pub Date : 2024-07-11 DOI: 10.15585/mmwr.mm7327a4

引用次数: 0

Notes from the Field: Illnesses After Administration of Presumed Counterfeit Botulinum Toxin in Nonmedical Settings - Tennessee and New York City, March 2024. 现场笔记：2024 年 3 月，田纳西州和纽约市，在非医疗场所使用假冒肉毒杆菌毒素后出现的疾病。

IF 25.4 1区医学

MMWR. Morbidity and mortality weekly report Pub Date : 2024-07-11 DOI: 10.15585/mmwr.mm7327a3

Christine M Thomas, Roisin McElroy, Jane Yackley, Mary-Margaret A Fill, Dilani Goonewardene, Christian Mackley, Emma Roth, Joel Ackelsberg, Sally Slavinski, Caroline Habrun, Bethany Hodge, Carrell Rush, Catherine M Brown, Michelle A Waltenburg, Lindsay H Bertling, Milan McGorty, Renee Johnson, William Schaffner, Timothy F Jones, John R Dunn

引用次数: 0

Notes from the Field: Respiratory Viral Panel as an Early Diagnostic Tool for Neonatal Enterovirus Infection - San Diego, California 2023. 现场笔记：呼吸道病毒样本作为新生儿肠道病毒感染的早期诊断工具 - 加利福尼亚州圣地亚哥，2023 年。

IF 25.4 1区医学

MMWR. Morbidity and mortality weekly report Pub Date : 2024-07-11 DOI: 10.15585/mmwr.mm7327a2

Ryan Sanchez, Errica Capossela, Mark Speziale, Jane O'Donnell, Amaran Moodley, Christina Morales, Debra A Wadford, Carol Glaser, Seema Shah, Mark E Beatty, Alice Pong

引用次数: 0

QuickStats: Age-Adjusted Death Rate* Among Adults Aged ≥65 Years, by Sex - United States, 1970-2022. QuickStats：1970-2022年美国≥65岁成年人按年龄调整后的死亡率*，按性别分列。

IF 25.4 1区医学

MMWR. Morbidity and mortality weekly report Pub Date : 2024-07-04 DOI: 10.15585/mmwr.mm7326a3

引用次数: 0